Epithalon in Telomere and Longevity Research

Epithalon and Telomere Protection in Longevity Research

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

What is Epithalon?

Epithalon is a synthetic tetrapeptide composed of four amino acids, originally derived from the naturally occurring pineal gland peptide known as epithalamin. First identified in the late 1980s by Prof. Vladimir Khavinson at the Sankt Petersburg University in Russia, Epithalon has since been widely studied for its potential influence on cellular aging.

Its primary function lies in regulating the cell cycle by enhancing telomerase activity, a mechanism directly tied to telomere maintenance and longevity. Beyond this, Epithalon has demonstrated antioxidant, anti-inflammatory, and anti-tumor properties in both animal models and human clinical studies.

Source: PubChem

Biological Functions of the Pineal Peptide

The pineal gland plays a central role in regulating endocrine and metabolic processes, including pituitary activity, calcium metabolism, gonadotropin release, and melatonin production. Epithalamin, the natural counterpart of Epithalon, exhibits antioxidant activity, improves stress resistance, and helps reduce corticosteroid levels. These functions suggest broad applications for Epithalon in modulating aging, immune response, and systemic resilience.

Mechanistic Pathways

Telomerase and Telomere Maintenance

Epithalon exerts its primary action through stimulation of telomerase, an RNA-dependent polymerase that extends telomeres at the ends of chromosomes. By preventing excessive telomere shortening, cells retain proliferative capacity and avoid premature senescence. While unchecked telomerase activity can drive neoplastic transformation, controlled telomere stabilization has been shown to promote longevity and delay tumorigenesis.

Antioxidant Properties

Epithalon demonstrates strong antioxidant effects, reducing cellular damage from reactive oxygen species. Oxidative stress is closely linked to DNA damage, apoptosis, and oncogenic mutations. By mitigating this process, Epithalon supports genomic stability and cellular health.

Tumor-Suppressive Activity

Research indicates Epithalon inhibits cancer progression by downregulating carcinogenic receptor expression, reducing metastatic potential, and slowing tumor growth in models of breast, colorectal, and other hormone-dependent cancers.

Modulation of Inflammation

Epithalon helps regulate immune signaling pathways by influencing cytokines, C-reactive protein, and other acute-phase proteins. Proper modulation of these mediators is essential to preventing chronic inflammation, which contributes to autoimmune disease and tissue damage.

Endocrine Regulation

By supporting telomere integrity, Epithalon also influences hormonal balance.

Evidence from Research Studies

Extensive investigations into Epithalon have demonstrated a range of physiological effects:

• Activation of telomerase and elongation of telomeres
  
• Normalization of antioxidant indices
  
• Reduction in lipid peroxidation
  
• Enhancement of glutathione peroxidase activity
  
• Improved immune function, both cellular and humoral
  
• Increased melatonin secretion
  
• Improved insulin sensitivity
  
• Reduction of LDL and VLDL cholesterol levels
  
• Enhanced tissue repair capacity
  
• Tumor-inhibitory effects
  

Expanded Findings

Effects on Aging

Human and animal studies show Epithalon induces telomerase activity and telomere elongation, with one report noting a 33% increase in telomere length in human somatic cells.

Oncostatic Activity in Experimental Models

Multiple experimental models reveal Epithalon’s oncostatic properties, including inhibition of mammary tumors, colon cancer, and hormone-dependent malignancies.

Inflammatory Pathway Regulation

By influencing pro- and anti-inflammatory mediators, Epithalon contributes to the resolution of chronic inflammation.

Telomeres as a Biomarker of Aging

Telomeres are repeats of the nucleotide sequence TTAGGG that cap the ends of chromosomes. Stem cells, embryonic cells and germ cells keep their telomeres long through telomerase, but its activity falls with age in most somatic cells, and the resulting telomere attrition is closely linked to cellular dysfunction.

Telomere length is shaped by both genetic and epigenetic factors, and it correlates strongly with DNA methylation, so the two are studied together as biomarkers of aging. Short telomeres are associated with cardiovascular disease, type 2 diabetes, osteoporosis, depression and obesity, and older individuals with short telomeres show higher mortality from cardiovascular and infectious disease. In aged telomerase-deficient mice, reactivating telomerase reversed tissue degeneration.

Additional Experimental Evidence

Epithalon has the amino acid sequence Ala-Glu-Asp-Gly. In vitro, it reactivated ribosomal genes in senescent lymphocytes and promoted chromatin decondensation, restoring transcription in regions silenced by age-related chromatin condensation.

In Drosophila, epithalon extended lifespan by 11–16% across several strains at extremely low concentrations. In CBA mice it delayed reproductive aging, inhibited oxidative processes and reduced spontaneous tumor incidence. In aged female rhesus monkeys, it restored the daily rhythm of melatonin and cortisol secretion.

In female Swiss-derived SHR mice, long-term epithalon administration delayed the end of the estrous cycle, reduced chromosomal aberrations in bone marrow cells, extended maximum lifespan by more than 12% and significantly lowered the incidence of leukemia.

REFERENCES

1. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003 Jun;135(6):590-2. doi: 10.1023/a:1025493705728. PMID: 12937682.
2. Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer. 2002 Sep 1;101(1):7-10. doi: 10.1002/ijc.10570. PMID: 12209581.
3. Korkushko OV, Khavinson VKh, Shatilo VB, Antonyuk-Shcheglova IA. Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging. Bull Exp Biol Med. 2006 Sep;142(3):356-9. English, Russian. doi: 10.1007/s10517-006-0365-z. PMID: 17426848.
4. Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003 Jun-Aug;24(3-4):233-40. PMID: 14523363.
5. Khavinson VKh, Bioregulating therapy as a new direction in Medicine,Proceedings of the National conference of Gerontology and Geriatrics;May 28-31, 1997 Bucharest, Romainia;1997 p205
6. Jaskelioff M, Muller FL, Paik JH, et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011;469:102-106. doi: 10.1038/nature09603.
7. Anisimov VN, Khavinson VKh, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. doi: 10.1023/a:1025114230714.
8. Lu AT, Seeboth A, Tsai PC, et al. DNA methylation-based estimator of telomere length. Aging (Albany NY). 2019;11(16):5895-5923. doi: 10.18632/aging.102173.
9. Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28-34. doi: 10.1097/MCO.0b013e32834121b1.

Product available for research use only: